| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |